Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study

14 Oct 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Respiratory viral infections research
Share to Virology and Viral Diseases
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39419046
DOI: 10.1016/s1473-3099(24)00570-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world studyPMID 39419046Read ↗

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.Semantic proximity Read ↗

Respiratory Syncytial virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab ProphylaxisSemantic proximity Read ↗

Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.Semantic proximity Read ↗

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsSemantic proximity Read ↗

Virological and Clinical Outcomes in Adults Treated with Ribavirin Aerosol for COVID-19 PneumoniaSemantic proximity Read ↗

Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysisSemantic proximity Read ↗

Respiratory Syncytial Virus.Semantic proximity Read ↗

Understanding and interpreting PRRSV diagnostics in the context of “disease transition stages”Semantic proximity Read ↗

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus.Semantic proximity Read ↗

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.Semantic proximity Read ↗

Functional Characterization of RSV Clades Associated with Prophylactic Breakthrough Infections in Pediatric Transmission ClustersSemantic proximity Read ↗

Clinical Phenotypes and Molecular Characteristics of Respiratory Syncytial Virus in Adults: A Monocentric Prospective Study Between 2019 and 2022.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.